Asia Pacific Healthcare Artificial Intelligence (AI) Market size crossed USD 274 million in 2020 and is set to observe around 48% growth rate between 2021 and 2027 impelled by the rapid growth in the development of AI technology to increase the quality-of-care delivery.

Asia Pacific Healthcare AI Market Growth Outlook 2021-2027

Asia Pacific Healthcare AI Market Size By Application (Medical Imaging & Diagnosis, Drug Discovery, Therapy Planning, Hospital Workflow, Wearables, Virtual Assistants), Research Report, Country Outlook (Japan, China, India, Australia, Singapore, South Korea, New Zealand, Indonesia, Thailand), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 – 2027 

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Methodology

1.2&nbsp;&nbsp;&nbsp; Market definition

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; Data sources

1.4.1&nbsp;&nbsp;&nbsp; Secondary

1.4.1.1&nbsp;&nbsp;&nbsp; Paid sources

1.4.1.2&nbsp;&nbsp;&nbsp; Unpaid sources

1.4.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Asia Pacific healthcare artificial intelligence industry 3600 synopsis, 2016 - 2027

2.1.1&nbsp;&nbsp;&nbsp; Country trends

2.1.2&nbsp;&nbsp;&nbsp; Application trends

Chapter 3&nbsp;&nbsp;&nbsp;Asia Pacific Healthcare Artificial Intelligence Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2016 - 2027

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp; Rising adoption of healthcare artificial intelligence in research areas

3.3.1.2&nbsp;&nbsp;&nbsp; Increasing range of future applications

3.3.1.3&nbsp;&nbsp;&nbsp; Advancements in big data analytics

3.3.1.4&nbsp;&nbsp;&nbsp; Favorable funding scenario

3.3.1.5&nbsp;&nbsp;&nbsp; Potential to increase quality of care delivery

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp; High initial capital requirement

3.3.2.2&nbsp;&nbsp;&nbsp; Large scale human unemployment

3.3.2.3&nbsp;&nbsp;&nbsp; Difficulty in deployment

3.4&nbsp;&nbsp;&nbsp; Analysis of COVID-19 impact on the industry

3.5&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.6&nbsp;&nbsp;&nbsp; Competitive landscape, 2020

3.7&nbsp;&nbsp;&nbsp; PEST analysis

Chapter 4&nbsp;&nbsp;&nbsp;Asia Pacific Healthcare Artificial Intelligence Market, By Application

4.1&nbsp;&nbsp;&nbsp; Market trends

4.2&nbsp;&nbsp;&nbsp; Medical imaging &amp; diagnosis

4.2.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.3&nbsp;&nbsp;&nbsp; Drug discovery

4.3.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.4&nbsp;&nbsp;&nbsp; Therapy planning

4.4.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.5&nbsp;&nbsp;&nbsp; Hospital workflow

4.5.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.6&nbsp;&nbsp;&nbsp; Wearables

4.6.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.7&nbsp;&nbsp;&nbsp; Virtual assistants

4.7.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

4.8&nbsp;&nbsp;&nbsp; Others

4.8.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by country, 2016 - 2027 (USD Million)

Chapter 5&nbsp;&nbsp;&nbsp;Asia Pacific Healthcare Artificial Intelligence Market, By Country

5.1&nbsp;&nbsp;&nbsp; Market trends

5.2&nbsp;&nbsp;&nbsp; Japan

5.2.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by application, 2016 - 2027 (USD Million)

5.3&nbsp;&nbsp;&nbsp; China

5.3.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by application, 2016 - 2027 (USD Million)

5.4&nbsp;&nbsp;&nbsp; India

5.4.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by application, 2016 - 2027 (USD Million)

5.5&nbsp;&nbsp;&nbsp; Australia

5.5.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by application, 2016 - 2027 (USD Million)

5.6&nbsp;&nbsp;&nbsp; Singapore

5.6.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by application, 2016 - 2027 (USD Million)

5.7&nbsp;&nbsp;&nbsp; South Korea

5.7.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by application, 2016 - 2027 (USD Million)

5.8&nbsp;&nbsp;&nbsp; New Zealand

5.8.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by application, 2016 - 2027 (USD Million)

5.9&nbsp;&nbsp;&nbsp; Indonesia

5.9.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by application, 2016 - 2027 (USD Million)

5.10&nbsp;&nbsp;&nbsp; Thailand

5.10.1&nbsp;&nbsp;&nbsp; Market estimate and forecast, by application, 2016 - 2027 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Company Profiles

6.1&nbsp;&nbsp;&nbsp; AiCure

6.1.1&nbsp;&nbsp;&nbsp; Business overview

6.1.2&nbsp;&nbsp;&nbsp; Financial data

6.1.3&nbsp;&nbsp;&nbsp; Product landscape

6.1.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.2&nbsp;&nbsp;&nbsp; APIXIO, Inc

6.2.1&nbsp;&nbsp;&nbsp; Business overview

6.2.2&nbsp;&nbsp;&nbsp; Financial data

6.2.3&nbsp;&nbsp;&nbsp; Product landscape

6.2.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.3&nbsp;&nbsp;&nbsp; Atomwise, Inc.

6.3.1&nbsp;&nbsp;&nbsp; Business overview

6.3.2&nbsp;&nbsp;&nbsp; Financial data

6.3.3&nbsp;&nbsp;&nbsp; Product landscape

6.3.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.4&nbsp;&nbsp;&nbsp; Butterfly Network, Inc.

6.4.1&nbsp;&nbsp;&nbsp; Business overview

6.4.2&nbsp;&nbsp;&nbsp; Financial data

6.4.3&nbsp;&nbsp;&nbsp; Product landscape

6.4.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.5&nbsp;&nbsp;&nbsp; Cyrcadia Health Inc.

6.5.1&nbsp;&nbsp;&nbsp; Business overview

6.5.2&nbsp;&nbsp;&nbsp; Financial data

6.5.3&nbsp;&nbsp;&nbsp; Product landscape

6.5.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.6&nbsp;&nbsp;&nbsp; Enlitic, Inc.

6.6.1&nbsp;&nbsp;&nbsp; Business overview

6.6.2&nbsp;&nbsp;&nbsp; Financial data

6.6.3&nbsp;&nbsp;&nbsp; Product landscape

6.6.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.7&nbsp;&nbsp;&nbsp; IBM (Watson Health)

6.7.1&nbsp;&nbsp;&nbsp; Business overview

6.7.2&nbsp;&nbsp;&nbsp; Financial data

6.7.3&nbsp;&nbsp;&nbsp; Product landscape

6.7.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.8&nbsp;&nbsp;&nbsp; iCarbonX

6.8.1&nbsp;&nbsp;&nbsp; Business overview

6.8.2&nbsp;&nbsp;&nbsp; Financial data

6.8.3&nbsp;&nbsp;&nbsp; Product landscape

6.8.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.9&nbsp;&nbsp;&nbsp; Insilico Medicine Inc

6.9.1&nbsp;&nbsp;&nbsp; Business overview

6.9.2&nbsp;&nbsp;&nbsp; Financial data

6.9.3&nbsp;&nbsp;&nbsp; Product landscape

6.9.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.10&nbsp;&nbsp;&nbsp; NVIDIA Corporation

6.10.1&nbsp;&nbsp;&nbsp; Business overview

6.10.2&nbsp;&nbsp;&nbsp; Financial data

6.10.3&nbsp;&nbsp;&nbsp; Product landscape

6.10.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.11&nbsp;&nbsp;&nbsp; Modernizing Medicine

6.11.1&nbsp;&nbsp;&nbsp; Business overview

6.11.2&nbsp;&nbsp;&nbsp; Financial data

6.11.3&nbsp;&nbsp;&nbsp; Product landscape

6.11.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.12&nbsp;&nbsp;&nbsp; OmeCare Inc.

6.12.1&nbsp;&nbsp;&nbsp; Business overview

6.12.2&nbsp;&nbsp;&nbsp; Financial data

6.12.3&nbsp;&nbsp;&nbsp; Product landscape

6.12.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.13&nbsp;&nbsp;&nbsp; Sens.ly Inc.

6.13.1&nbsp;&nbsp;&nbsp; Business overview

6.13.2&nbsp;&nbsp;&nbsp; Financial data

6.13.3&nbsp;&nbsp;&nbsp; Product landscape

6.13.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.14&nbsp;&nbsp;&nbsp; Sophia Genetics

6.14.1&nbsp;&nbsp;&nbsp; Business overview

6.14.2&nbsp;&nbsp;&nbsp; Financial data

6.14.3&nbsp;&nbsp;&nbsp; Product landscape

6.14.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.15&nbsp;&nbsp;&nbsp; Welltok

6.15.1&nbsp;&nbsp;&nbsp; Business overview

6.15.2&nbsp;&nbsp;&nbsp; Financial data

6.15.3&nbsp;&nbsp;&nbsp; Product landscape

6.15.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.16&nbsp;&nbsp;&nbsp; Zebra Medical Vision Ltd

6.16.1&nbsp;&nbsp;&nbsp; Business overview

6.16.2&nbsp;&nbsp;&nbsp; Financial data

6.16.3&nbsp;&nbsp;&nbsp; Product landscape

6.16.4&nbsp;&nbsp;&nbsp; Strategic outlook

6.17&nbsp;&nbsp;&nbsp; Johnson and Johnson

6.17.1&nbsp;&nbsp;&nbsp; Business overview

6.17.2&nbsp;&nbsp;&nbsp; Financial data

6.17.3&nbsp;&nbsp;&nbsp; Product landscape

6.17.4&nbsp;&nbsp;&nbsp; Strategic outlook 
&nbsp;